Decoding body odor to reveal invisible early signals.
What we do
SenseBioTek develops an AI-augmented electronic nose platform designed to detect early signals by transforming emitted body odors into actionable insights for preventive healthcare and other high-impact sectors.
Our mission
Our vision
Our values
SenseBioTek’s mission is to turn body odor into a measurable marker by developing reliable decoding solutions that identify early signals before they become critical, with major applications in healthcare and other high-impact sectors.
Our vision is to build a new form of intelligence based on odor, transforming invisible signals into early insights that guide decisions upstream.
Innovation: "Exploring, experimenting, progressing"
At SenseBioTek, innovation means continuously exploring new technological solutions, experimenting, and adapting to challenges in order to rethink prevention and upstream decision-making. We move forward with rigor and agility to turn invisible signals into meaningful information.
Reliability: "From science to decision"
Our commitment to reliability is grounded in strong scientific and technological rigor. It ensures that our solutions are not technology demonstrators, but true decision-support tools designed to deliver robust, actionable, and trustworthy information.
Collective intelligence: "Building together"
At SenseBioTek, collective intelligence lies at the core of our approach. It is built through co-creation with our teams, partners, and domain experts. Field experience, collaboration, and shared commitment are essential to developing sustainable solutions with lasting impact.


Our Technology
Volatile organic compounds (VOCs) are molecules naturally emitted by the human body, reflecting its internal biological state.
In the presence of imbalance or disease, these chemical signatures evolve, generating early signals with high informational value.
SenseBioTek leverages these signals through an AI-augmented electronic nose platform combining:
For our research and development projects, SenseBioTek relies on a dedicated high-resolution chromatography system designed to identify and characterize volatile molecular signatures.
Nanosensor-based detection systems


Patented VOC collection devices, SkinVOCs®


Advanced decoding algorithms


Applications
Healthcare: Early detection through body odor
Healthcare is the primary application area of SenseBioTek.
By decoding body-emitted odors, our platform enables the identification of early signals associated with serious diseases, before obvious clinical symptoms appear.
This approach supports non-invasive prevention, earlier decision-making, and improved care pathways, particularly for conditions where time is a critical factor.
Additional body odor–based applications:
Beyond healthcare, decoding body odor can create significant value in other contexts where odor reflects a physiological state, an imbalance, or individual characteristics.
These applications may include, for example:
wellness and preventive monitoring,
physiological state tracking,
cosmetic applications, particularly for understanding individual olfactory signatures, assessing product effectiveness, and developing personalized solutions,
and more broadly, any use case requiring the analysis of non-invasive biological signals.
Other applications: Beyond body odor
Odor decoding extends beyond human body odor.
The development of applications involving other types of odors—including environmental, industrial, and security-related odors—is led by our subsidiary SenseDetecte, which is dedicated to these domains.
👉 Discover SenseDetecte
Academic Partners








Scientific Committee












Pr Jean-Luc Perrot
Dermatologie-Oncologie
CHU de St Etienne
Dr Didier Thiebaut
Directeur de Recherches,
UMR8231
LSABM ESPCI Paris PSL, CNRS
Dr Jérôme VIAL
Professeur en Chimie,
UMR8231
LSABM, ESPCI Paris PSL
Pr Benoît Piro
Professeur en Chimie & Biocapteurs,
Université Paris Cité,
Print’Up Institute
Dr Bérengère Lebantal
Ingénieure en Chef des Eaux, des Ponts et des Forêts
Laboratoire IMSE
Université Gustave Eiffel.
Dr José Dugay
Maître de Conférences,
UMR8231
LSABM, ESPCI Paris PSL


Incubators & Accelerators










Institutional Supporters






Award Winner 2024








The Team


Nabil Moumane (MD)
CEO & Founder
Nathalie Gagey-Eilstein (PhD)
Chief Technology Officer (CTO)
Kleidisa Rrushka
Chemical Engineer Analytique


Sarah ELIRAKI (MD)
Chief Medical Officer (CMO)


Lambert Trenoras (PhD)
Business Dev. Officer (BDO)


Emilie Duval
Chemical Engineer & Mines
Project Manager R&D


